Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-042582

ImmunityBio, Inc. · IBRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Patrick Soon-Shiong
Officer — Chairman and CEO · Director · 10% Owner
Period of report
Jul 11, 2018
Accepted (ET)
Jul 13, 2018 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 11, 2018M9,257$1.6204A40,565,814ISee footnote
Common StockF2holding———5,618,326ISee footnote
Common Stockholding———600,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to buy)F4,F3$1.6204Jul 11, 2018M9,257D—Jul 27, 2018Common Stock9,2570I

Explanation of responses